1. Introduction {#sec1}
===============

Abnormal uterine bleeding accounts for approximately 20% of visits to gynaecology clinics and almost 25% of gynaecological operations in the UK \[[@B9]\].

40% of premenopausal women with abnormal uterine bleeding were found to have some intrauterine pathology \[[@B7]\]. Uterine fibroids (approximately 30%) and polyps (approximately 10%) are the most common form of pathology found \[[@B13]\].

A combination of diagnostic hysteroscopy with the histological examination of any endometrial aspirate or biopsy is considered as the "gold standard" for the diagnosis of intrauterine abnormalities \[[@B4]\].

Advances in ultrasound scanning technology have revolutionised the noninvasive diagnosis of uterine pathology. However, despite these developments, it is still not possible to visualize some problems with confidence, such as intrauterine adhesions \[[@B1]\]. Differentiating submucous fibroids from endometrial polyps can be difficult sometimes \[[@B3], [@B11]\]. Another example is distinguishing submucous fibroids which distort the cavity from those not distorting the cavity \[[@B12]\]. These differentiations become extremely important when the decision to treat and how to treat has to be made.

Uterine hydrosonography (HSGM) (also known as saline infusion sonography (SIS)) involves real time ultrasound visualization of the uterus during distension of the cavity with a sonolucent material which is usually sterile normal saline. The introduction of this technique has improved the diagnostic capability of ultrasound so that it has become a competitive method for visualization of uterine cavity pathology \[[@B10]\].

When compared to outpatient hysteroscopy, HSGM is less invasive \[[@B18]\], causes less pain and discomfort \[[@B16]\], carries no risk of uterine corporeal perforation, and is cheaper \[[@B6]\].

In spite of these advantages, HSGM is not widely available, neither is it much in use compared to TVS and hysteroscopy. We therefore considered it important to establish its efficacy and safety firmly before recommending its widespread use.

We have conducted this retrospective study to assess the diagnostic efficacy of HSGM as a tool for evaluating uterine intracavity lesions.

2. Materials and Methods {#sec2}
========================

This is a retrospective observational study conducted at the Central Middlesex Hospital, London, which is a district general hospital serving a multiethnic population of North West London. The data was collected for a three-year period, from 1 January 2008 to 31 December 2010.

All the women who underwent a transvaginal ultrasound scan (TVS) evaluation together with a HSGM as part of their gynaecological investigations were identified from hospital data. Those who were suspected of having uterine intracavity lesions (by TVS or HSGM) underwent hysteroscopy and excision/biopsy of any suitable identified lesions.

The patient demographics, TVS, HSGM, hysteroscopy, and histology findings (if performed) were collected from the hospital patient records and from the hospital electronic reporting systems. Those with incomplete data were excluded from the analysis.

All TVS were performed by qualified sonographers in the ultrasound scan department. HSGM was largely performed by one consultant gynaecologist with a special interest in subfertility and a few were performed by senior trainees in gynaecology using a Sonoace 8000 SE ultrasound machine with a curvilinear transvaginal probe of frequency range 4 to 9 MHz.

A 5.2 FGr Goldstein catheter (Cook® Medical Inc, Ireland) was introduced into the uterine cavity and sterile 0.9% saline was injected via the catheter into the uterine cavity as the distension medium. All diagnostic hysteroscopies were performed under general anaesthesia using a 5 mm rigid, single flow, 30-degree-angle scope (Karl Storz, Tuttlingen, Germany) with sterile 0.9% saline as the distension medium.

Microsoft Excel 2010 and MedCalc version 11.5.1.0 were used for validation tests (sensitivity, specificity, and positive and negative predictive values) and analysis. Only those women who underwent all three procedures (TVS, HSGM, and hysteroscopy) were included in the validation test analysis.

3. Results {#sec3}
==========

Out of 223 patients whose records were examined, 13 were excluded due to incomplete data; 210 patients were included in this analysis. Patient characteristics and the indication for the investigations are detailed in [Table 1](#tab1){ref-type="table"}. 76 patients underwent hysteroscopy due to suspected intracavity lesions on HSGM and uterine cavity lesions were confirmed in 74 patients ([Table 2](#tab2){ref-type="table"}).

There were no documented complications during or after the HSGM procedure in this study. The HSGM procedure was completed successfully in 99.52% of patients (1 HSGM was abandoned due to patient discomfort; however, a second attempt on a different day was successful).

TVS was "normal" in 32 patients. However, 9 of these were found to have intracavity pathology on HSGM (cervical polyp: 1, endometrial polyp: 4, submucous fibroid: 2, and Asherman\'s syndrome: 2).

Two women were diagnosed with intrauterine adhesions (Asherman\'s syndrome) by HSGM although the TVS failed to identify this problem in both cases.

Two women who were investigated for intermenstrual bleeding were found to have anterior isthmic defects (a consequence of previous lower segment caesarean section (LSCS)) by HSGM as the cause for their intermenstrual bleeding. Both of these isthmic defects were not identified by TVS.

The diagnostic efficacy of TVS and HSGM for the diagnosis of endometrial polyps and submucous fibroids were calculated by the validation tests shown in [Table 3](#tab3){ref-type="table"}.

*For the Diagnosis of Endometrial Polyps*. TVS showed a sensitivity of 60.53%, specificity of 97.06%, and positive predictive value (PPV) and negative predictive value (NPV) of 95.83% and 68.75%, respectively. HSGM showed a sensitivity of 95%, specificity of 97.14%, PPV 97.44%, and NPV 94.44%.

*For the Diagnosis of Submucous Leiomyoma*. TVS showed a sensitivity of 57.14%, specificity 93.48%, PPV 84.21%, and NPV 78.18%, whereas HSGM showed a sensitivity of 96.55%, specificity 100.00%, PPV 100.00%, and NPV 97.92%.

4. Discussion {#sec4}
=============

Our study confirms that HSGM has a higher sensitivity and specificity as well as positive and negative predictive values for the diagnosis of endometrial polyps and submucous fibroids when compared with TVS. It also confirms that the HSGM procedure has a low failure rate, in contrast to at least one other published study which claimed a failure rate of 7% \[[@B7]\].

Our lower failure rate could be due to the inclusion of very few postmenopausal women in our study (postmenopausal women, 1.5%) together with the high percentage of multiparous women in our study (63.34%). Studies have shown that postmenopausal status and nulliparity were associated with higher failure rates \[[@B4], [@B14], [@B5]\].

Another relevant factor may be operator experience as more than 98% of the HSGM procedures were performed by a single, experienced operator with more than 15 years\' experience of performing HSGM. If this assumption is true, we suggest that the failure rate will fall further with increasing operator experience.

A systematic review of diagnostic hysteroscopy in abnormal uterine bleeding \[[@B17]\] concluded that the sensitivity and specificity of hysteroscopy to diagnose endometrial polyps was 0.94 (95% CI 0.92 to 0.96) and 0.92 (95% CI 0.91 to 0.94), respectively. For the diagnosis of submucous myomata, the sensitivity was 0.87 (95% CI 0.81 to 0.92) with a specificity of 0.95 (95%CI 0.93 to 0.97). The efficacy of hysteroscopy in their study is comparable to our findings for HSGM and it can therefore be concluded that HSGM is as effective as hysteroscopy for the diagnosis of endometrial polyps and submucous fibroids. This has been confirmed in other studies as well \[[@B15]\].

HSGM has the advantage of being less invasive and less expensive and it causes less patient discomfort and inconvenience. It also enabled us to quantify the lesions by measuring them and determining the position of the lesions accurately, relative to the myometrium \[[@B10]\]. During the uterine cavity examination, HSGM also provides an opportunity for the examiner to evaluate other uterine and pelvic structures at the same sitting.

The accuracy of the measurements obtained by the use of the sonolucent medium within the uterine cavity facilitates the choice of evidence-based treatment options. For example, the length of the uterine septum of up to 1 cm appears not to worsen reproductive performance and may not need surgical correction to improve reproductive outcome \[[@B8]\]. This can be accurately measured during HSGM but not quite as easily or readily using TVS alone.

HSGM identified 2 isthmic defects as the cause for intermenstrual bleeding (both missed by TVS). This is an important diagnosis for the management of these patients appropriately and, in these cases, the diagnosis was only secured by HSGM.

Patients tolerated the HSGM procedure well. Only 1 procedure out of 210 had to be abandoned due to patient discomfort. It also caused less inconvenience to the patients when compared to the impact of hysteroscopy as they were able to carry on with their normal daily routine immediately after the procedure.

This study confirmed that the diagnostic accuracy of HSGM for the diagnosis of endometrial polyps and submucous fibroids is as effective as hysteroscopy. Even though hysteroscopy offers the advantage of "see and treat" option, hysteroscopy (as both an outpatient and inpatient procedure) costs more than HSGM \[[@B16]\] and is more invasive.

Why should we choose an invasive option which causes more discomfort and involves more complications as well as a greater cost when the same objective can be achieved by a less invasive option? HSGM should therefore be considered as an intermediate procedure, before embarking on the more invasive hysteroscopy option. We are confident that the application of the HSGM technique in the management of abnormal uterine bleeding will eventually result in a significant reduction in the use of hysteroscopy (with its associated complications and greater costs) for diagnostic purposes.

4.1. Strengths and Limitations {#sec4.1}
------------------------------

One of the limitations was the retrospective collection of data. However, even though it was a retrospective study, the quality of data was extremely good. Out of 223 cases only 13 were excluded due to incomplete data. The findings are more representative for premenopausal than postmenopausal women as 98.5% of data was collected from premenopausal women.

However its value in postmenopausal women was established in a recent study \[[@B2]\] which concluded that HSGM is an easy to perform, safe, and well-tolerated procedure yielding high diagnostic accuracy in postmenopausal women.

5. Conclusion {#sec5}
=============

It is clear from this study that the diagnostic efficacy of HSGM is superior to TVS for the diagnosis of endometrial polyps and submucous fibroids. When our findings are compared with that of the meta-analysis for hysteroscopy \[[@B2]\] it is obvious that HSGM is a competitive alternative to diagnostic hysteroscopy.

Given that HSGM is less invasive, carries no perforation risk, causes less discomfort and inconvenience, and costs less to carry out, it should be considered as an intermediate investigation after TVS to assess intracavity pathology and to confirm the diagnosis; hysteroscopy should become a therapeutic intervention and should primarily be reserved for this purpose in the future. A prospective observational study with cost evaluation is desirable to confirm the cost effectiveness of this approach.

The authors are grateful to Mrs. Chris Todd RGN, MRCN (Senior Fertility Nurse Specialist), who played a key role in establishing and maintaining the HSGM service at the hospital. They also thank the unit trainees during this study period (Dr. Sumathi Sentilkumar MRCOG, Dr. Nandita Deo MRCOG, Dr. Sangeeta Sawant MRCOG, and Dr. Indranil Saha MRCOG) all of whom helped to carry out the HSGMs whilst maintaining the good quality data which has been used in this study.

Ethical Approval
================

No ethics committee approval was required.

Disclosure
==========

The study was registered as a service evaluation audit (Department of Research and Development, North West London Hospitals NHS Trust).

Competing Interests
===================

Nii Adjeidu Armar received sponsorship and consultation fees from Cook Medical, Ireland, for carrying out seminars and workshops on saline uterine hydrosonography.

###### 

Patient characteristics and indication for investigations.

  --------------------------------------- ------------------------------
  Age in years, mean ± SD (range)         38.79 ± 7.68 (21--66)
                                          (Postmenopausal -- 3 (1.5%))
  Parity, median (range)                  1 (0--8)
  BMI, mean ± SD (range)                  27.98 ± 5.99 (18--50)
  Ethnicity, *n* (%)                       
   Asian                                  52 (27.46%)
   Black Afro-Caribbean                   95 (45.24%)
   Caucasians                             29 (13.81%)
   Not recorded                           22 (10.47%)
   Others                                 12 (5.71%)
                                          
  Principle presenting symptom, *n* (%)    
   Menorrhagia                            119 (56.667%)
   Subfertility                           23 (10.952%)
   Chronic pelvic pain                    17 (8.1%)
   Intermenstrual bleed                   12 (5.714%)
   Dysmenorrhoea                          10 (4.762%)
   Irregular bleeding                     14 (6.66%)
   Other                                  15 (7.143%)
  --------------------------------------- ------------------------------

###### 

Intracavity lesions confirmed by hysteroscopy.

  Intracavity lesion                Numbers
  --------------------------------- ---------
  Asherman\'s syndrome              2
  Endometrial polyp                 38
  Endo. polyp + submucous fibroid   2
  IUCD                              2
  Polypoid endometrium              3
  Submucous fibroid                 26
                                    
  *Total*                           *74*

###### 

Validation tests for TVS and HSGM for the diagnosis of endometrial polyps and submucous fibroids.

                       TVUSS                            HSGM                                   
  -------------------- ------------- ------------------ ------------------ ------------------- ------------------
  Endometrial polyps   Sensitivity   60.53%             43.39% to 75.96%   95.00%              83.08% to 99.39%
  Specificity          97.06%        84.67% to 99.93%   97.14%             85.08% to 99.93%    
  Positive PV          95.83%        78.88% to 99.89%   97.44%             86.52% to 99.94%    
  Negative PV          68.75%        53.75% to 81.34%   94.44%             81.34% to 99.32%    
                                                                                               
  Submucous fibroids   Sensitivity   57.14%             37.18% to 75.54%   96.55%              82.24% to 99.91%
  Specificity          93.48%        82.10% to 98.63%   100.00%            92.45% to 100.00%   
  Positive PV          84.21%        60.42% to 96.62%   100.00%            87.66% to 100.00%   
  Negative PV          78.18%        64.99% to 88.19%   97.92%             88.93% to 99.95%    
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